Cargando…

Immunotherapy with an HIV-DNA Vaccine in Children and Adults

Therapeutic HIV immunization is intended to induce new HIV-specific cellular immune responses and to reduce viral load, possibly permitting extended periods without antiretroviral drugs. A multigene, multi-subtype A, B, C HIV-DNA vaccine (HIVIS) has been used in clinical trials in both children and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palma, Paolo, Gudmundsdotter, Lindvi, Finocchi, Andrea, Eriksson, Lars E., Mora, Nadia, Santilli, Veronica, Aquilani, Angela, Manno, Emma C., Zangari, Paola, Romiti, Maria Luisa, Montesano, Carla, Grifoni, Alba, Brave, Andreas, Ljungberg, Karl, Blomberg, Pontus, Bernardi, Stefania, Sandström, Eric, Hejdeman, Bo, Rossi, Paolo, Wahren, Britta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494215/ https://www.ncbi.nlm.nih.gov/pubmed/26344746 http://dx.doi.org/10.3390/vaccines2030563

Ejemplares similares

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation
por: Bråve, Andreas, et al.
Publicado: (2010)

Therapeutic DNA Vaccination of Vertically HIV-Infected Children: Report of the First Pediatric Randomised Trial (PEDVAC)
por: Palma, Paolo, et al.
Publicado: (2013)

Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment
por: Roos, Anna-Karin, et al.
Publicado: (2009)

Do circulating HIV vaccine plasmids contribute to immunogenicity in humans?
por: Wahren, B, et al.
Publicado: (2006)

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: Study of immunological memory and long-term toxicology
por: Bråve, Andreas, et al.
Publicado: (2007)

Potent cellular and humoral immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use
por: Wahren, Britta, et al.
Publicado: (2006)

A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines
por: Hallengärd, David, et al.
Publicado: (2012)

Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment
por: Rivalta, Beatrice, et al.
Publicado: (2022)

Burkitt's lymphoma mimicking EBV disease as first sign of vertical HIV infection in an adolescent
por: Santilli, Veronica, et al.
Publicado: (2010)

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial
por: Nilsson, Charlotta, et al.
Publicado: (2015)

HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV
por: Hinkula, J, et al.
Publicado: (2017)

An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo
por: Yu, Feifan, et al.
Publicado: (2014)

Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child
por: Palma, Paolo, et al.
Publicado: (2016)

Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity
por: Boberg, Andreas, et al.
Publicado: (2012)

Waning of vaccine-induced immunity to measles in kidney transplanted children
por: Rocca, Salvatore, et al.
Publicado: (2016)

Immunization with HIV protease peptides linked to syngeneic erythrocytes
por: Boberg, Andreas, et al.
Publicado: (2007)

Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients
por: Cifaldi, Cristina, et al.
Publicado: (2021)

Tailored treatments in inborn errors of immunity associated with atopy (IEIs-A) with skin involvement
por: Giancotta, Carmela, et al.
Publicado: (2023)

Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children
por: Cotugno, Nicola, et al.
Publicado: (2020)

P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA
por: Bakari, M, et al.
Publicado: (2009)

Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART
por: Zicari, Sonia, et al.
Publicado: (2019)

Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice
por: Kumawat, Ashok Kumar, et al.
Publicado: (2022)

Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors
por: Pontrelli, Giuseppe, et al.
Publicado: (2012)

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children
por: Palma, P, et al.
Publicado: (2015)

Immunoinformatic Docking Approach for the Analysis of KIR3DL1/HLA-B Interaction
por: Grifoni, Alba, et al.
Publicado: (2013)

60 Years of viral vaccines
por: Wahren, Britta
Publicado: (2022)

P19-29. Determining the optimal protocol for plasmid DNA vaccine delivery by intradermal in vivo electroporation
por: Hallengärd, D, et al.
Publicado: (2009)

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
por: Malm, Magdalena, et al.
Publicado: (2013)

Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
por: Malm, Magdalena, et al.
Publicado: (2013)

Targeted treatment of autoimmune cytopenias in primary immunodeficiencies
por: Pacillo, Lucia, et al.
Publicado: (2022)

CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization
por: Katinger, D, et al.
Publicado: (2012)

Micro-minicircle Gene Therapy: Implications of Size on Fermentation, Complexation, Shearing Resistance, and Expression
por: Stenler, Sofia, et al.
Publicado: (2014)

Declining HIV-1 prevalence and incidence among Police Officers – a potential cohort for HIV vaccine trials, in Dar es Salaam, Tanzania
por: Munseri, Patricia J, et al.
Publicado: (2013)

OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines
por: Cotugno, Nicola, et al.
Publicado: (2019)

Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis
por: Klint, Susanne, et al.
Publicado: (2023)

Case Report: Two Cases of Pediatric Thrombotic Thrombocytopenic Purpura Treated With Combined Therapy
por: Tripiciano, Costanza, et al.
Publicado: (2021)

Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality
por: Elmén, Joacim, et al.
Publicado: (2005)

Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies
por: Cotugno, Nicola, et al.
Publicado: (2021)

DNA Vaccines: Recent Developments and the Future
por: Wahren, Britta, et al.
Publicado: (2014)

Novel Compound Heterozygous Mutations in IL-7 Receptor α Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment
por: Zangari, Paola, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hc1r2g7pa818324cbqd2pdq06j